ADIAL PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Adial Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $124K, a 38.7% decline year-over-year.
  • Adial Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $729K, a 25.4% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $797K, a 54.4% decline from 2023.
  • Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.75M, a 48.2% decline from 2022.
  • Adial Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.37M, a 20.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $797K -$950K -54.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $1.75M -$1.63M -48.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $3.37M -$866K -20.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $4.24M +$2.82M +199% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.42M Jan 1, 2020 Dec 31, 2020 10-K 2021-03-22
2018 $252K +$116K +85.4% Jan 1, 2018 Dec 31, 2018 10-K 2019-02-19
2017 $136K Jan 1, 2017 Dec 31, 2017 10-K 2019-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.